Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: KLARQUIST SPARKMAN, LLP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-12-14 to 2024-03-13
Current total value of award: $14274
Description: 24-003787 NHLBI REQUIRES THE FILING OF A PROVISIONAL PATENT APPLICATION IN ORDER TO ESTABLISH A PRIORITY DATE TO AN INVENTION COVERING DUAL VARIABLE DOMAINS ENHANCED HLA-INDEPENDENT T CELL RECEPTORS MODIFIED T CELLS TARGETING CT-RCC-1 PEPTIDE DERIVED